Drugs May Cost Too Much, But Patents Are Not the Cause | McDonnell Boehnen Hulbert & Berghoff LLP

For at least a decade, Congress has been concerned (not to say obsessed) with drug costs (understandably so, no matter how ineffective; see "FTC to the Rescue Regarding High Drug Prices...

Related Keywords

New York ,United States ,David Gaugh ,New York Times ,Congress Regarding Prescription Drug ,Generic Pharmaceutical Association ,Association For Accessible Medicines ,Rescue Regarding High Drug Prices ,More Ill Conceived Remedies ,Ill Conceived Remedies ,Senate Once Again Tries ,Address Drug Pricing ,Accessible Medicines ,Best Solution ,Reducing Drug ,Biologics Price Competition ,Innovation Act ,Improving Medicare ,Populist Patent Fantasies ,Journal Joins ,York Times ,